Peptide Therapeutics Market Insights: Revenue Expected to Surpass $74.98 Billion by 2029

Uncover key drivers, emerging technologies, and competitive movements shaping the peptide therapeutics market from 2025–2034 with trusted insights from The Business Research Company

What Is The Current Size And Expected Growth Outlook For The Peptide Therapeutics Market?

The peptide therapeutics market size has experienced significant expansion in recent years. It is anticipated to increase from $45.15 billion in 2024 to $49.21 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.0%. This historical growth can be ascribed to factors such as the increasing incidence of chronic diseases, a growing understanding of molecular biology, and expanding applications in oncology.

The peptide therapeutics market is projected to experience substantial expansion over the upcoming years. This market is forecast to reach $74.98 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 11.1%. This anticipated growth is driven by several factors, including the increasing need for personalized medicine, broader applications in immunotherapy, innovations in peptide delivery mechanisms, the identification of new peptide targets for infectious diseases, and a heightened emphasis on rare conditions. Key trends influencing the market during this period encompass technological progress in peptide synthesis, an increase in investment and funding, a strong focus on the safety of peptide drugs, market penetration into developing economies, and the incorporation of artificial intelligence (AI).

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7216&type=smp

Which Growth Drivers Are Propelling The Peptide Therapeutics Market?

The rising incidence of chronic illnesses is projected to fuel expansion in the peptide therapeutics market. These are persistent health conditions that are frequently incurable, though sometimes manageable or curable. Their rise is linked to factors such as increased tobacco consumption, inadequate nutrition, lack of physical activity, and excessive alcohol intake, among others. Peptide therapeutics play a role in preventing and treating specific chronic ailments. For example, a January 2023 report from the US-based National Library of Medicine indicated that the population in the US aged 50 and above with at least one chronic ailment is anticipated to grow by 99.5%, reaching 142.66 million by 2050. Consequently, the growing prevalence of chronic conditions is set to drive the peptide therapeutics market throughout the projected period.

Which Segmentation Factors Are Most Significant In The Peptide Therapeutics Market Analysis?

The peptide therapeutics market covered in this report is segmented –

1) By Type: Generic, Branded

2) By Route of Administration: Parenteral, Mucosal, Oral, Transdermal

3) By Application: Cancer, Cardiovascular Diseases, Central Nervous Systems, Metabolic Disorders, Infections, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders, Acromegaly, Other Applications

Subsegments:

1) By Generic: Generic Peptide Drugs, Biosimilars

2) By Branded: Innovative Peptide Drugs, Patent-Protected Peptides

What New Opportunities Are Emerging From Trends In The Peptide Therapeutics Market?

Leading companies in the peptide therapeutics market are focused on introducing advanced solutions, such as the cell culture process, to gain a competitive advantage. The cell culture process is the method of cultivating cells outside their natural setting, under controlled environments, involving the isolation of specific cells from living tissue and their subsequent maintenance. For instance, in June 2023, Evonik Industries AG, a German-based specialty chemicals company, launched cQrex KC. cQrex KC is a next-generation peptide for biopharma applications, specifically designed for the cell culture process utilized in manufacturing biological drugs. It empowers cell culture process developers to optimize cystine supply and enhance cell culture productivity. cQrex KC supports the creation of vaccines, viral vectors, and cell therapies.

Who Are The Most Influential Companies In The Peptide Therapeutics Market?

Major companies operating in the peptide therapeutics market include Pfizer Inc., Jhonson & Jhonson, Abbvie Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca plc, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk AS, Teva Pharmaceuticals Industries Ltd., Bachem Holding AG, PolyPeptide Laboratories BV, Arcus Biosciences Inc., Pepscan Therapeutics, Peptech Inc., Peptide Logic Inc., SELLAS Life Sciences Group, Ever Neuro Pharma GmbH, Zealand Pharma AG, PepGen Inc., Pepticom S.A., Peptide Technologies Corporation, SynPeptide Inc., Peptimmune Inc., Merck & Co Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

Which Region Holds The Largest Share In The Peptide Therapeutics Market Today?

North America was the largest region in the peptide therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=7216&type=smp

Browse Through More Reports Similar to the Global Peptide Therapeutics Market 2025, By The Business Research Company

Biosimilar Therapeutic Peptide Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biosimilar-therapeutic-peptide-global-market-report

Nutraceuticals Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/nutraceuticals-global-market-report

Oral Biologics And Biosimilars Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/oral-biologics-and-biosimilars-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795